By early May 2026, Indonesia’s Free Health Screening program, known as CKG, had reached 100 million people since launching on Feb. 10, 2025. It now operates in over 10,000 community health centers across 514 districts and cities.
The scale alone is historic. Yet officials say the real significance is not how many people were screened, but what the screenings reveal about the nation’s health beneath the surface.
For the first time, Indonesia has a structured, nationwide health profile spanning every age group—from newborns to the elderly—built from tens of millions of real-world medical checks.
The emerging national “health map,” however, paints a troubling picture. Far from reassuring, it exposes widespread and systemic health risks across nearly every demographic.
Ministry of Health data from 2025 shows consistent patterns: about six percent of newborns are underweight, one in three toddlers has dental decay, and one in five adolescents already shows elevated blood pressure.
Among adults, the picture worsens. One in three suffers from central obesity, while more than half of elderly participants are diagnosed with hypertension, signaling deep, long-term chronic disease burdens.
The most alarming findings come from school-age children. Between January and early May 2026, 4.8 million children were screened, and more than 22 percent — about 663,000 — were found to have high blood pressure.
That discovery challenges long-held assumptions that hypertension is largely an adult or elderly condition, raising urgent questions about early lifestyle and environmental risks.
Among adults, nearly 96 percent of participants were classified as physically inactive. Roughly one-third were obese, and nearly a quarter were overweight, according to the latest CKG data.
Officials link these trends to rising consumption of ultra-processed foods high in salt, sugar, and fat, combined with persistently low levels of physical activity across the population.
What CKG confirms is that these are no longer isolated lifestyle risks. They now represent a dominant national pattern shaping Indonesia’s long-term health trajectory.
Hidden cases
Beyond broad statistics, the program’s most striking contribution is its exposure of disease that had remained invisible for years.
Health officials estimate that around 70 percent of people with diabetes and three times that share of hypertension patients were previously unaware of their conditions before joining CKG screenings.
This reflects Indonesia’s historically reactive health system, where care is typically sought only after symptoms appear and daily functioning is disrupted by illness.
Routine preventive checks have not been a cultural norm, allowing slow-developing non-communicable diseases to progress unnoticed until they reach severe stages.
Indonesia is estimated to have 65 million people with hypertension and 30 million with diabetes, both major drivers of premature death and long-term disability.
Left uncontrolled, both conditions can trigger kidney failure, strokes, and heart attacks—catastrophic outcomes that carry heavy human and financial costs.
In 2023 alone, Indonesia’s national health insurer BPJS Kesehatan spent Rp22.8 trillion (US$1.3 billion) on cardiovascular disease linked to hypertension, part of Rp34.8 trillion spent on non-communicable diseases.
Officials say delayed diagnosis remains one of the biggest contributors to those rising costs and preventable complications.
The CKG program initially focused on detection in its first year, but in 2026 shifted toward immediate intervention after diagnosis.
Patients identified with health problems now receive up to 15 days of free treatment, with continued care covered under the national health insurance system for eligible participants.
Starting in 2026, patients diagnosed with hypertension or diabetes through CKG can receive same-day medication directly at community health centers, without hospital referral.
The policy is designed to fix a critical gap identified in 2025, when many diagnosed patients never received sustained follow-up care.
Ministry data shows only about one-third of hypertension patients consistently take medication, while fewer than 10 percent of diabetes patients achieve controlled blood sugar levels.
A parliamentary review found that of 16.8 million patients requiring follow-up, only 1.4 million received continued treatment—underscoring a vast care gap.
A national health map
Beyond clinical use, CKG is increasingly functioning as a policy engine, shaping how Indonesia designs health interventions at local and national levels.
In Jakarta, for example, screenings found 74 percent of participants had abnormal cholesterol levels, 93 percent were physically inactive, and 51 percent had dental health problems.
Local authorities are now using that data to design targeted prevention campaigns rather than relying on broad, one-size-fits-all public health messaging.
Previously, Indonesia relied heavily on periodic surveys such as the Basic Health Research study, known as Riskesdas, conducted only every few years with limited samples.
CKG now produces a far larger and continuously updated dataset covering nearly the entire country, though data quality still varies between health facilities.
The Health Ministry is integrating CKG with BPJS Kesehatan systems to ensure smoother referrals and reduce financial barriers to continued care.
For 2026, the government aims to expand coverage to 130 million people, or about 46 percent of the population, supported by the military, police, workplaces, and schools.
But gaps remain. Participation is lowest in eastern provinces, including North Kalimantan, Central Papua, Southwest Papua, and Highland Papua.
Even in accessible regions, uptake is uneven due to limited awareness and lingering skepticism toward preventive health checks.
Local government commitment also varies widely, with some regions exceeding targets through aggressive outreach, while others lag due to administrative and logistical constraints.
After more than a year, CKG has evolved into a continuously updated national health database—something Indonesia has never had at this scale.
Its long-term value may lie in its ability to reshape the country’s chronic disease burden, reducing deaths from heart disease, stroke, and kidney failure.
But that outcome depends on whether the data is acted on decisively—or remains just another record of problems already too widespread to ignore.
Related news: Free health screening program reaches 100 million Indonesians
Related news: Free Health Check program reaches 10.5 million participants in 2026
Editor: Rahmad Nasution
Copyright © ANTARA 2026
